In a previous communication describing the pulmonary excretion of C1402 in patients following the intravenous administration of 100 microcuries of glycine-2-C14 it was demonstrated that approximately 83 to 92 per cent was excreted via the lungs and that approximately 3 to 5 per cent was excreted within the urine in the first 10 days ( 1 ) . 2 At that time preliminary autopsy data on one patient disclosed that about 10 per cent of the C14 was retained in compounds having a longer turnover time than the slowest component of excretion in the breath, namely the 7-to 14-day component. Since the publication of this paper three additional patients who were given C14 labeled glycine for the study of the life span of the red blood cell in leukemia and polycythemia vera have come to autopsy. The present paper reports the tissue C14 levels found in these patients.
METHODS
The patients had been given 100 microcuries (8.2 mg.) of glycine-2-CG4 (methylene labeled) as described previously. Autopsies were carried out as soon as possible and in no case later than 12 hours after death. Samples of fresh tissue were taken in Patients 1, 3, and 4. In Patient 2 the samples had been placed in formalin for five to 10 minutes before the blocks were recut and tissue taken. The tissue was cut into approximately one gram samples and dried in vacuo. The bone sample was taken from the body of the sternum. The dried tissue was then combusted to carbon dioxide using a chromic-sulfuric acid oxidizing mixture (3). The carbon dioxide was precipitated as barium carbonate, the radioactivity of which was measured by the use of a vibrating reed electrometer and a 100 cc. ionization chamber operating at atmospheric pressure (4, 5) .
RESULTS
The specific activity of the tissues is presented in Table I . Figure 1 shows the specific activity of the lungs, the myocardium, the kidney, and the liver of the four patients plotted on semilogarithmic paper as a function of time.
DISCUSSION
The table shows that within 57 days after administration the tissue concentrations in Patient 1 ranged from 0.04 dis./min./mg. of barium carbonate in the fat to 0.74 dis./min./mg. of barium carbonate in the spleen. If the fat is excluded from consideration, the range of specific activities in this patient was from 0.12 to 0.74 dis./min./mg. BaCO8, or an approximately sixfold variation. It is interesting to note in this patient that the specific activity of the bone is near the average of all the tissues and that there are several tissues, particularly the myocardium, skeletal muscle, and the spleen, in which specific activity was considerably higher than that of the bone. In Patient 2 only five tissues were available, and these had been previ- ously slightly fixed in formalin so that although the data are probably reliable, the specific activities may be low. The tissues from this patient also show a comparatively small range of specific activities. The third patient shows a range of specific activities from a tissue in which no specific activity could be determined, the fat, to one in which the specific activity was 0.42 dis./min./mg. BaCO,. Here also the skeletal muscle was the tissue with the highest specific activity. In Patient 4, who was autopsied 526 days after administration of the C14 labeled glycine, it is interesting to note that there is still a measurable amount of C14 present. It should be pointed out, however, that with the exception of skeletal muscle and the whole blood, the tissues are all close to the limit of resolution for the method of measurement of C14 which is employed (4, 5) . Nevertheless, in each instance there was present a small, definite, and measurable quantity of activity; however, the actual numerical values are subject to considerable error at this level, and the value should not be regarded as highly precise.
Because all of these patients had lost considerable weight during the terminal phases of their illnesses, it is somewhat difficult to determine the precise amount of C14 present at autopsy; but in Patient 4 it can be estimated that approximately 1-2 per cent of the dose had been retained as late as 526 days. Figure 1 shows that for the four organs from which samples are available from all patients there appears to be a common component of elimination of C14. As can be seen from the data on Patient 4, the values anticipated by extrapolation from the first three patients are considerably lower than those actually obtained at 526 days. This would indicate that there is another component of elimination having a half-time longer than 50 days.
From the data on the elimination of C14 in the breath, it was postulated that there should be another component of elimination from the body with a half-time of at least 90 days. Study of the long-term urinary C14 excretion shows that there is a component of urinary C14 excretion with a halftime of approximately 50 days (6) . This is in close agreement with the anticipated value found from the tissue studies reported here 1. The autopsy data on four patients given glycine-2-C14 are presented.
2. It has been shown that there is no marked concentration of the glycine-2-14 in the bone and that with the exception of fat, which is very low in concentration, the tissue concentrations do not differ markedly.
3. There is a half-time of C14 elimination from the tissues which is approximately 50 days.
4. Autopsy of the fourth patient 526 days after administration indicates that there is at least one other component of elimination slower than 50 days.
